Context: Have a paper process for travel approvals and reconciliations within our organization. Long-term plan is to revise the business process but in the meantime, we need to capture travel information from our end users that is currently housed in multiple forms and sy...
These include two breakthrough drugs approved by the US FDA: Luspatercept-aamt, the first medicine approved for patients with low-risk myelodysplastic syndrome (MDS) in more than a decade; and Ozanimod, an oral medicine for the treatment of adults with relapsing forms of multiple sclerosis....
Gilenya is approved to treat relapsing forms of multiple sclerosis (MS) in adults. First Pediatric DMT Approval Gilenya is also approved to treat children and adolescents with relapsing MS who are 10 years of age and older.8 How It's Taken Gilenya is taken once a day by mouth with or ...
Right now I am struggling with accessing anything I don't explicitly "own", even though I am a member of Approvals App Admin Team. Custom approval templates are actually forms and I need to be able to read their responses, which is why I am in this game. It's a specific case within...
AUBAGIO is a pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiplesclerosis(MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. (1)
Approval of peginterferon beta-1a was based on the results of the ADVANCE clinical trial which compared peginterferon (125 mcg every 2 weeks or every 4 weeks) to placebo. The annualized relapse rate at 48 weeks was 0.256 for the peginterferon every 2-week group, 0.288 for the every 4-week...
Filed underUncategorizedand tagged5 years,60 minutes,HSCT,Moscow,multiple sclerosis,post-transplant,recovery,Redbury new York,russia,stem cell transplant,the ms gym,Travelon,warrior|18 Comments No More Monsters I Can Breathe Again – Part 1
The article reports on the approval of the oral drug Tecfidera from Biogen Idec by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis (MS). The company's study confirms that people taking the drug ...
Tecfidera is FDA-approved for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It received FDA approval on March 27, 2013, for Biogen Inc., Cambridge, MA 02142....
However, when one creates a custom template for Approvals the additional fields are behind-the-scenes created in the Forms repository, so the data collected as part of the custom approval workflow ends up in the forms responses - not in CDS/dataverse - which is why I need to bother with ...